• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
    • Social Work Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
    • Psychiatry News Videos
    • Medication Guide Videos
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • FAQs
  • Med Fact Book App
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » The molecular mechanism of antipsychotic- induced weight gain is found

The molecular mechanism of antipsychotic- induced weight gain is found

May 1, 2007
From The Carlat Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
James Ellison, MD, MPH

We’ve known for some time now that clozapine and Zyprexa (olanzapine) cause the most weight gain of any antipsychotic, but we didn’t know the actual mechanism – until now. Researchers from Johns Hopkins and the University of Vermont found that both clozapine and Zyprexa increase levels of a specific enzyme in the hypothalamus that boosts the appetite. The enzyme, AMPK (AMP-protein kinase), is one of the brain's major fuel-sensors, and leads to various biochemical reactions that eventually cause weight gain and metabolic abnormalities. Atypical antipsy- chotics that cause little weight gain, such as Risperdal, Abilify, and Geodon, increase AMPK levels only minimally. Interestingly, the way clozapine and Zyprexa stimulate AMPK appears to be via histamine-1 receptor antagonism, a neurotransmitter pathway that has long been a prime suspect as a mediator of weight gain (Kim SF et al., Proc Nat Acad Sci 2007:104(9): 3456-3459).

TCPR’s Take: It’s rare to find a clear molecular explanation for anything in psychiatry, so this finding is intriguing for that reason alone. Are there any clinical implications? Not really, since we already knew which antipsychotics caused the most weight gain. But researchers will use these findings to develop more targeted medica- tions, both to prevent and to treat obesity in our psychotic patients.

General Psychiatry
KEYWORDS antipsychotics
    www.thecarlatreport.com
    Issue Date: May 1, 2007
    SUBSCRIBE NOW
    Table Of Contents
    Medications for Dementia: An Update
    Normal Forgetfulness vs. Pre-Dementia: How to Distinguish Them
    Agitation and Depression in Older Patients
    Antidepressants shown ineffective for bipolar depression
    FDA orders consumer medication guides for stimulants
    The molecular mechanism of antipsychotic- induced weight gain is found
    TMS for the treatment of auditory hallucinations
    DOWNLOAD NOW
    Featured Book
    • MFB7e_Print_App_Access.png

      Medication Fact Book for Psychiatric Practice, Seventh Edition (2024) - Regular Bound Book

      The updated 2024 reference guide covering the most commonly prescribed medications in psychiatry.
      READ MORE
    Featured Video
    • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
      General Psychiatry

      KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

      Read More
    Featured Podcast
    • shutterstock_2622607431.jpg
      General Psychiatry

      Should You Test MTHFR?

      MTHFR is a...
      Listen now
    Recommended
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png

    About

    • About Us
    • CME Center
    • FAQ
    • Contact Us

    Shop Online

    • Newsletters
    • Multimedia Subscriptions
    • Books
    • eBooks
    • ABPN Self-Assessment Courses

    Newsletters

    • The Carlat Psychiatry Report
    • The Carlat Child Psychiatry Report
    • The Carlat Addiction Treatment Report
    • The Carlat Hospital Psychiatry Report
    • The Carlat Geriatric Psychiatry Report
    • The Carlat Psychotherapy Report

    Contact

    carlat@thecarlatreport.com

    866-348-9279

    PO Box 626, Newburyport MA 01950

    Follow Us

    Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

    © 2025 Carlat Publishing, LLC and Affiliates, All Rights Reserved.